将循环 microRNA-126-3p 鉴定为冠状动脉钙化的新生物标记物。

IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL
SAGE Open Medicine Pub Date : 2024-08-18 eCollection Date: 2024-01-01 DOI:10.1177/20503121241272646
Xia Zhang, Mengmeng Zhu, Peng Zeng, Mingxiu Guan, Hongyu Zhang, Shaohua Duan, Heli Huang, Yulian Liu, Hongliang Cong, Yuanli Chen
{"title":"将循环 microRNA-126-3p 鉴定为冠状动脉钙化的新生物标记物。","authors":"Xia Zhang, Mengmeng Zhu, Peng Zeng, Mingxiu Guan, Hongyu Zhang, Shaohua Duan, Heli Huang, Yulian Liu, Hongliang Cong, Yuanli Chen","doi":"10.1177/20503121241272646","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Several circulating microRNAs, including microRNA-126-3p, have been identified as diagnostic and prognostic biomarker of cardiovascular disease. However, whether microRNA-126-3p is an independent risk predictor for coronary artery calcification is unclear.</p><p><strong>Methods: </strong>In this prospective single-center study, we collected blood samples from coronary artery atherosclerosis patients (<i>n</i> = 54), patients with coronary artery calcification (<i>n</i> = 33) and controls (<i>n</i> = 56). Total RNA was extracted from plasma and blood cells with TRIzol reagents. The microRNA-126-3p level was determined via quantitative real-time polymerase chain reaction (RT-PCR).</p><p><strong>Results: </strong>MicroRNA-126-3p levels were significantly increased in patients with coronary artery calcification than in coronary artery atherosclerosis patients or controls. The highest expression of microRNA-126-3p was observed in patients with moderate calcification who were diagnosed with Grade 2 calcification by coronary angiography. Age, microRNA-126-3p expression in veins, hypertension and diabetes significantly influence the occurrence of coronary artery calcification, among which diabetes and venous microRNA-126-3p expression were found to be independent risk factors for coronary artery calcification.</p><p><strong>Conclusions: </strong>Taken together, the data in this study suggest that circulating microRNA-126-3p may be a novel noninvasive biomarker for coronary artery calcification. Regulating microRNA-126-3p expression may be an effective and promising strategy for the diagnosis and treatment of cardiovascular diseases, especially coronary artery calcification.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241272646"},"PeriodicalIF":2.3000,"publicationDate":"2024-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11331480/pdf/","citationCount":"0","resultStr":"{\"title\":\"Identification of circulating microRNA-126-3p as a new biomarker for coronary artery calcification.\",\"authors\":\"Xia Zhang, Mengmeng Zhu, Peng Zeng, Mingxiu Guan, Hongyu Zhang, Shaohua Duan, Heli Huang, Yulian Liu, Hongliang Cong, Yuanli Chen\",\"doi\":\"10.1177/20503121241272646\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Several circulating microRNAs, including microRNA-126-3p, have been identified as diagnostic and prognostic biomarker of cardiovascular disease. However, whether microRNA-126-3p is an independent risk predictor for coronary artery calcification is unclear.</p><p><strong>Methods: </strong>In this prospective single-center study, we collected blood samples from coronary artery atherosclerosis patients (<i>n</i> = 54), patients with coronary artery calcification (<i>n</i> = 33) and controls (<i>n</i> = 56). Total RNA was extracted from plasma and blood cells with TRIzol reagents. The microRNA-126-3p level was determined via quantitative real-time polymerase chain reaction (RT-PCR).</p><p><strong>Results: </strong>MicroRNA-126-3p levels were significantly increased in patients with coronary artery calcification than in coronary artery atherosclerosis patients or controls. The highest expression of microRNA-126-3p was observed in patients with moderate calcification who were diagnosed with Grade 2 calcification by coronary angiography. Age, microRNA-126-3p expression in veins, hypertension and diabetes significantly influence the occurrence of coronary artery calcification, among which diabetes and venous microRNA-126-3p expression were found to be independent risk factors for coronary artery calcification.</p><p><strong>Conclusions: </strong>Taken together, the data in this study suggest that circulating microRNA-126-3p may be a novel noninvasive biomarker for coronary artery calcification. Regulating microRNA-126-3p expression may be an effective and promising strategy for the diagnosis and treatment of cardiovascular diseases, especially coronary artery calcification.</p>\",\"PeriodicalId\":21398,\"journal\":{\"name\":\"SAGE Open Medicine\",\"volume\":\"12 \",\"pages\":\"20503121241272646\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-08-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11331480/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"SAGE Open Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/20503121241272646\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"SAGE Open Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20503121241272646","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:包括microRNA-126-3p在内的几种循环microRNA已被确定为心血管疾病的诊断和预后生物标志物。然而,microRNA-126-3p 是否是冠状动脉钙化的独立风险预测因子尚不清楚:在这项前瞻性单中心研究中,我们收集了冠状动脉粥样硬化患者(54 人)、冠状动脉钙化患者(33 人)和对照组(56 人)的血液样本。用 TRIzol 试剂从血浆和血细胞中提取总 RNA。微RNA-126-3p水平通过实时定量聚合酶链反应(RT-PCR)测定:结果:与冠状动脉粥样硬化患者或对照组相比,冠状动脉钙化患者的 microRNA-126-3p 水平明显升高。经冠状动脉造影诊断为 2 级钙化的中度钙化患者的 microRNA-126-3p 表达量最高。年龄、静脉中microRNA-126-3p的表达、高血压和糖尿病对冠状动脉钙化的发生有显著影响,其中糖尿病和静脉中microRNA-126-3p的表达是冠状动脉钙化的独立危险因素:综上所述,本研究的数据表明,循环 microRNA-126-3p 可能是冠状动脉钙化的一种新型无创生物标志物。调节microRNA-126-3p的表达可能是诊断和治疗心血管疾病,尤其是冠状动脉钙化的有效且有前景的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Identification of circulating microRNA-126-3p as a new biomarker for coronary artery calcification.

Objective: Several circulating microRNAs, including microRNA-126-3p, have been identified as diagnostic and prognostic biomarker of cardiovascular disease. However, whether microRNA-126-3p is an independent risk predictor for coronary artery calcification is unclear.

Methods: In this prospective single-center study, we collected blood samples from coronary artery atherosclerosis patients (n = 54), patients with coronary artery calcification (n = 33) and controls (n = 56). Total RNA was extracted from plasma and blood cells with TRIzol reagents. The microRNA-126-3p level was determined via quantitative real-time polymerase chain reaction (RT-PCR).

Results: MicroRNA-126-3p levels were significantly increased in patients with coronary artery calcification than in coronary artery atherosclerosis patients or controls. The highest expression of microRNA-126-3p was observed in patients with moderate calcification who were diagnosed with Grade 2 calcification by coronary angiography. Age, microRNA-126-3p expression in veins, hypertension and diabetes significantly influence the occurrence of coronary artery calcification, among which diabetes and venous microRNA-126-3p expression were found to be independent risk factors for coronary artery calcification.

Conclusions: Taken together, the data in this study suggest that circulating microRNA-126-3p may be a novel noninvasive biomarker for coronary artery calcification. Regulating microRNA-126-3p expression may be an effective and promising strategy for the diagnosis and treatment of cardiovascular diseases, especially coronary artery calcification.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
SAGE Open Medicine
SAGE Open Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
3.50
自引率
4.30%
发文量
289
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信